What Earnings Calls And SEC Filings Reveal About The State Of Pharma

View at publisher Summarise with VIRAT
Authors: Richard G. Frank
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A review of pharmaceutical industry SEC filings and earnings calls reveals three major trends from 2017 to 2025: structural changes in research and development spending, cautious financial framing of most-favored-nation pricing agreements, and a continued emphasis on small molecule drug development.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Pharmaceutical industry and healthcare Financial Analysis and Corporate Governance

Publication details

Journal / source
Forefront Group
Publication date
31 March 2026
Language
EN
Document type
Dataset